In addition, TPCNM were primed with the conditional medium from CRC cells with KRAS mutation (DLD‐1, HCT116, LoVo, SW480, SW620) and those with BRAF mutation (HT‐29, WiDr). Here, KRAS is linked to colorectal carcinoma.